Interleukin-38 ameliorates poly(I:C) induced lung inflammation
IL-38, a potential therapeutic agent for lupus, inhibits lupus progression
Interleukin‐38 suppresses abdominal aortic aneurysm formation in mice by regulating macrophages in an IL1RL2‐p38 pathway‐dependent manner - Kurose - 2023 - Physiological Reports - Wiley Online Library
Frontiers Circulating interleukin-38 concentrations in healthy adults
IJMS, Free Full-Text
IJMS, Free Full-Text
IL‐38–mediated NLRP3/caspase‐1 inhibition is a disease‐modifying treatment for TMJ inflammation - Luo - 2022 - Annals of the New York Academy of Sciences - Wiley Online Library
Frontiers The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?
Interleukin-22 protects against non-typeable Haemophilus influenzae infection: alteration during chronic obstructive pulmonary disease
LAIR-1 limits macrophage activation in acute inflammatory lung injury - ScienceDirect
Interleukin‐38 suppresses abdominal aortic aneurysm formation in mice by regulating macrophages in an IL1RL2‐p38 pathway‐dependent manner - Kurose - 2023 - Physiological Reports - Wiley Online Library
